Sign In
Buy GSK
$50.67
-1.48 (-2.84%)
At Close: Jun 18, 2026
GSK Inks $2 Billion For Cough Medicine Biotech To Bolster Drug Pipeline
05:22am, Tuesday, 18'th Apr 2023
GSK said Bellus' experimental cough medicine could help treat millions of people with untreatable chronic coughs and had “significant sales potential” if approved.
GSK pays £1.6bn for Canada's Bellus Health
02:48am, Tuesday, 18'th Apr 2023
GSK PLC (LSE:GSK, NYSE:GSK) has paid around £1.6bn for Bellus Health (TSX:BLU) Inc, a Canada-based, late-stage biopharmaceutical company which specialises in respiratory treatments. The pharmaceutica
GSK to acquire U.S.-based BELLUS Health for $14.75 per share
02:33am, Tuesday, 18'th Apr 2023
GSK PLC said Tuesday that it has reached an agreement to buy the late-stage biopharmaceutical company Bellus Health Inc. BLU, +3.08% BLU, +2.83% for $14.75 a share in cash, representing a total equity
GSK reports positive phase 3 data for UTI oral antibiotic
02:58am, Monday, 17'th Apr 2023
GSK PLC GSK, -0.49% on Monday reported positive data from its phase 3 studies for gepotidacin, its late-stage oral antibiotic for uncomplicated urinary-tract infections in female adults and teenagers.
GSK growth outlook being overlooked due to Zantac concerns
07:56am, Wednesday, 12'th Apr 2023
GSK PLC (LSE:GSK, NYSE:GSK)'s growth outlook is being overlooked and the worst-case scenario for Zantac continues to be reflected in the share price. That's the view of Shore Capital which reiterated
GSK: Will vaccines do the trick? This leading bank has its say
12:19pm, Monday, 03'rd Apr 2023
Deutsche Bank repeated its ‘buy' advice and 1,700p price target for shares in GSK PLC (LSE:GSK, NYSE:GSK) in an update which assessed the news flow around its Hepatitis B research. Put simply, the l
J&J Drops Out Of A Key Race, Leaving Pfizer, GSK, Moderna To Duke It Out
08:48am, Friday, 31'st Mar 2023
Johnson & Johnson ducked out of the RSV vaccine race Wednesday, leaving Pfizer, GSK and Moderna to duke it out. The post J&J Drops Out Of A Key Race, Leaving Pfizer, GSK, Moderna To Duke It Out appear
GSK agrees HIV deal that gives lower income nations access to drug
06:33am, Thursday, 30'th Mar 2023
GSK PLC (LSE:GSK, NYSE:GSK) has entered into agreements with three firms to produce affordable generic versions of its long-lasting HIV prevention drug, cabotegravir, for use in lower-income countries
J&J backs out of RSV vaccine race with rivals Pfizer and GSK
12:28pm, Wednesday, 29'th Mar 2023
J&J lagged behind rival drugmakers Pfizer and GSK, both of which made major strides toward U.S. approval of their RSV vaccines in the last month.
J&J Drops Out Of A Key Race, Leaving Pfizer, GSK, Moderna To Duke It Out
11:05am, Wednesday, 29'th Mar 2023
Johnson & Johnson ducked out of the RSV vaccine race Wednesday, leaving Pfizer, GSK and Moderna to duke it out. The post J&J Drops Out Of A Key Race, Leaving Pfizer, GSK, Moderna To Duke It Out appear
GSK's Jemperli Effective Against First-Line Endometrial Cancer
04:45pm, Tuesday, 28'th Mar 2023
A late-stage study data shows that GSK's Jemperli reduced disease progression risk or death by 72% for treating adult patients with dMMR/MSI-H primary advanced or recurrent endometrial cancer.
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
09:57am, Monday, 27'th Mar 2023
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Recent Stock Purchase March 2023
07:23am, Saturday, 25'th Mar 2023
I make a stock purchase every single month no matter what is going on in the world and despite the doom and gloom headlines. This month, I went heavier than I normally do, deploying over $3,000.
GSK Stock Skids On Judge's New Ruling As Zantac Trial Looms
11:03am, Friday, 24'th Mar 2023
A California judge will allow expert testimony linking GSK's heartburn drug Zantac to cancer. The decision took a bite out of GSK stock Friday.
GSK falls after Zantac expert opinion ruling in California litigation
08:13am, Friday, 24'th Mar 2023
GSK PLC (LSE:GSK, NYSE:GSK) shares fell 3.6% after it said it "respectfully disagrees" with a ruling by a California state court in litigation related to claims that the company's former heartburn
